$BNR News
Last published 2mo ago
- 2mo agoBNRBurning Rock Reports Second Quarter 2026 Financial ResultsGlobeNewswireGUANGZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next-generation sequencing
- 4mo agoBNRBurning Rock Announces Founder’s Purchase of Its ADSsGlobeNewswireGUANGZHOU, China, July 02, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focusing on the application of next generation sequencing
- 5mo agoBNRBurning Rock Reports First Quarter 2026 Financial ResultsGlobeNewswireGUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next-generation sequencing (NGS) technology in
- 6mo agoBNRBurning Rock Publishes 2025 Annual Report on Form 20-FGlobeNewswireGUANGZHOU, China, April 28, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing technology in the
- 7mo agoBNRBurning Rock Announces Founder's Purchase of Its ADSsGlobeNewswireGUANGZHOU, China, April 02, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focusing on the application of next generation sequencing (NGS) technology in
- 10mo agoBNRBurning Rock Announces Founder's Purchase of Its ADSsGlobeNewswireGUANGZHOU, China, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focusing on the application of next generation sequencing (NGS) technology in
- 10mo agoBNRBurning Rock Announces Results of 2025 Annual General MeetingGlobeNewswireGUANGZHOU, China, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock"), the "Company" or "Burning Rock"), a company focusing on the application of next generation
- 11mo agoBNRBurning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025GlobeNewswireGUANGZHOU, China, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock"), the "Company" or "Burning Rock"), a company focusing on the application of next generation
- 11mo agoBNRBurning Rock Reports Third Quarter 2025 Financial ResultsGlobeNewswireGUANGZHOU, China, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 1y agoBNRBurning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast CancerGlobeNewswireTOKYO and GUANGZHOU, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd. (Riken Genesis) and Burning Rock Biotech Limited (NASDAQ:BNR, "Burning Rock")) today announced that the OncoGuide™
- 1y agoBNRBurning Rock Reports Second Quarter 2025 Financial ResultsGlobeNewswireGUANGZHOU, China, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 1y agoBNRBurning Rock Reports First Quarter 2025 Financial ResultsGlobeNewswireGUANGZHOU, China, June 06, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 1y agoBNRBurning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewswireGUANGZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 1y agoBNRBurning Rock Announces Results of 2024 Annual General MeetingGlobeNewswireGUANGZHOU, China, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock"), the "Company" or "Burning Rock"), a company focusing on the application of next generation
- 1y agoBNRBurning Rock Reports Third Quarter 2024 Financial ResultsGlobeNewswireGUANGZHOU, China, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 1y agoBNRBurning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024GlobeNewswireGUANGZHOU, China, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock"), the "Company" or "Burning Rock"), a company focusing on the application of next generation
- 2y agoBNRNMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in ChinaGlobeNewswireGUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), an innovative company in the field of precision oncology, and Dizal, a global
- 2y agoBNRBurning Rock Announces Changes to Management and Board of DirectorsGlobeNewswireGUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR) (the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBurning Rock Reports Second Quarter 2024 Financial ResultsGlobeNewswireGUANGZHOU, China, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBurning Rock Biotech Limited Announces Expected Delisting of American Depositary SharesGlobeNewswireGUANGZHOU, China, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (the "Company" or "Burning Rock") announces that, on August 19, 2024, it intends to submit requests (a) to the London Stock Exchange (the
- 2y agoBNRBurning Rock Regains Compliance with NASDAQ Minimum Bid Price RequirementGlobeNewswireGUANGZHOU, China, June 03, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBayer and Burning Rock collaborate to increase patient access to precision cancer medicinesGlobeNewswireGUANGZHOU, China, May 30, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")) has recently announced a collaboration with Bayer to develop next-generation sequencing
- 2y agoBNRBurning Rock Biotech Limited (BNR) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBNRBurning Rock Reports First Quarter 2024 Financial ResultsGlobeNewswireGUANGZHOU, China, May 29, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in the
- 2y agoBNRBurning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024GlobeNewswireGUANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in the
- 2y agoBNRBurning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024GlobeNewswireGUANGZHOU, China, May 14, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in the
- 2y agoBNRBurning Rock Publishes 2023 Annual Report on Form 20-FGlobeNewswireGUANGZHOU, China, April 29, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing technology in the
- 2y agoBNRBurning Rock Announces ADS Ratio ChangeGlobeNewswireGUANGZHOU, China, April 26, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBurning Rock Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswireGUANGZHOU, China, March 28, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBurning Rock Announces Receipt of Notification from NASDAQGlobeNewswireGUANGZHOU, China, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBurning Rock Announces Results of 2023 Annual General MeetingGlobeNewswireGUANGZHOU, China, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focusing on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBurning Rock Biotech Limited (BNR) Q3 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBNRBurning Rock Reports Third Quarter 2023 Financial ResultsGlobeNewswireGUANGZHOU, China, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBurning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023GlobeNewswireGUANGZHOU, China, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focusing on the application of next generation sequencing (NGS) technology in
- 2y agoBNRBurning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023GlobeNewswireGUANGZHOU, China, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 3y agoBNRBurning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion DiagnosticsGlobeNewswireGUANGZHOU, China, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")) is pleased to announce that the Company and Boehringer Ingelheim officially have signed
- 3y agoBNRBurning Rock Received Breakthrough Device Designation from China's NMPA for its Multi-Cancer Early Detection TestGlobeNewswireGUANGZHOU, China, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")) is pleased to announce that followed an earlier Breakthrough Device Designation granted by
- 3y agoBNRBurning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer CellGlobeNewswireGUANGZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")) is delighted to announce that our personalized Minimal Residual Disease (MRD) product,
- 3y agoBNRBurning Rock Reports Second Quarter 2023 Financial ResultsGlobeNewswireGUANGZHOU, China, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 3y agoBNRBurning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023GlobeNewswireGUANGZHOU, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 3y agoBNRBurning Rock Announces Resignation and Appointment of DirectorsGlobeNewswireGUANGZHOU, China, June 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 3y agoBNRBurning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of MedicineGlobeNewswireGUANGZHOU, China, June 08, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")) is pleased to announce that our flagship comprehensive genomic profiling (CGP) product,
- 3y agoBNRBurning Rock Reports First Quarter 2023 Financial ResultsGlobeNewswireGUANGZHOU, China, May 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in the
- 3y agoBNRBurning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023GlobeNewswireGUANGZHOU, China, April 27, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 3y agoBNRBurning Rock Publishes 2022 Annual Report on Form 20-FGlobeNewswireGUANGZHOU, China, April 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing technology in the
- 3y agoBNRBurning Rock Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewswireGUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 3y agoBNRBurning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023GlobeNewswireGUANGZHOU, China, March 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 3y agoBNRBurning Rock provides an update on 2022 revenue guidanceGlobeNewswireGUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in
- 3y agoBNRBurning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood TestGlobeNewswireIRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced
- 3y agoBNRBurning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood TestPR NewswireIRVINE, Calif., Jan. 3, 2023 /PRNewswire/ -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that